Response to correspondence concerning "Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19".

Lallana, Sofia; Siegler, James E

Lallana, Sofia; Siegler, James E.

Lallana S; Neurology Department, Vall d'Hebron Universitary Hospital, Barcelona, Spain.
Siegler JE; Cooper Medical School of Rowan University, Camden, USA. Electronic address: siegler.james@gmail.com.

J Clin Neurosci ; 92: 189-190, 2021 10.

Article in English | MEDLINE | ID: covidwho-1356328

Subject(s)

COVID-19; Posterior Leukoencephalopathy Syndrome; COVID-19/complications; Humans; Posterior Leukoencephalopathy Syndrome/diagnostic imaging; Posterior Leukoencephalopathy Syndrome/etiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Posterior Leukoencephalopathy Syndrome / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: J Clin Neurosci Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: J.jocn.2021.08.006

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google